When shopping at a dispensary, many consumers gravitate toward indicas, sativas, or hybrids. It’s become the de facto way to classify cannabis products, with most menus matching this breakdown. However, connoisseurs argue that this breakdown is an inaccurate way to describe a weed strain’s effects—and it turns out, science may agree.
RELATED: The cannabis terms everyone uses (but not everyone understands)
A new systematic review published in the Journal of Cannabis Research examined available evidence to determine whether the labels actually corresponded to measurable differences in cannabis products or their effects. Scientists reviewed 28 peer-reviewed studies: 12 analyzed cannabis plants and products, 15 examined human outcomes, and one involved animals.
The researchers wanted to know whether the familiar classifications reflected meaningful differences in genetics, chemical composition, or consumer experiences. The overall consensus? The market may need to rethink how it does business.
The team found that plants sharing the same labels were typically not more genetically similar, and the categories did not reliably correspond to distinct chemical profiles. Some studies showed associations between certain terpenes and particular labels, but the results were inconsistent.
When it came to the human experience, findings were mixed. Some studies found associations between indica and sativa labels and certain outcomes, including insomnia relief and low-arousal effects. Researchers noted that differences in THC potency and other variables could influence outcomes, making it difficult to determine whether the labels themselves had any predictive value.
“The evidence does not support using indica, sativa, and hybrid labels as reliable guides to cannabis composition or therapeutic effects,” the authors wrote.
RELATED: The real reason weed names keep getting weirder
They added that consumers and clinicians should focus more on measurable product characteristics, such as dose, consumption method, and overall makeup of cannabinoids and terpenes. They cautioned, however, that evidence linking individual terpenes to specific effects remains preliminary.
The modern cannabis market is nuanced, and inconsistency reigns. Decades of crossbreeding have further blurred the lines between traditional indica and sativa varieties, raising questions about how useful those distinctions remain.
Strain names present another challenge. The same cultivar name can appear on products with different genetic backgrounds or chemical profiles, further complicating consumers’ efforts to know exactly what they’re buying.
Despite their scientific shortcomings, indica, sativa, and hybrid remain convenient marketing tools, giving retailers a simple way to organize products and consumers an easy starting point for shopping. But as the industry matures, the dispensary experience may evolve past these familiar categories.
